NCT05680350

Brief Summary

The study targets to evaluate the role of estimation of plasma expression levels of gene of microRNAs 203 and 210 in helping to diagnose and grade endometriosis. The study included women with unexplained infertility and clinical picture suggestive of presence of endometriosis were divided randomly into two groups: Control and study groups. All patients underwent exploratory laparotomy for diagnosis and grading of endometriosis if present. Patients of study group gave blood samples for estimation of plasma expression levels of microRNA 203 and 210 using qRT-PCR procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 7, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 12, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2022

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 26, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 11, 2023

Completed
Last Updated

January 11, 2023

Status Verified

December 1, 2022

Enrollment Period

1 year

First QC Date

December 26, 2022

Last Update Submit

January 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • grading of endometriosis

    The diagnostic performance of estimated plasma levels of microRNA for diagnosis and grading endometriosis

    8 months

Study Arms (2)

Study group

ACTIVE COMPARATOR

Study group Patients with unexplained infertility had estimated their Plasma Expression level for Gene"Micro RNA "203 \& 210" by qRT-PCR followed by laparoscopic exploration

Procedure: Laparoscopic ExplorationDiagnostic Test: Estimation of Plasma Expression level of MICRO RNA 203 & 210

Control Group

ACTIVE COMPARATOR

Control group Patients with unexplained infertility underwent laparoscopy only

Procedure: Laparoscopic Exploration

Interventions

Laparoscopic Exploration to diagnose \& grade endometriosis

Control GroupStudy group

estimation of Plasma Expression level for Gene"Micro RNA "203 \& 210" by qRT-PCR

Study group

Eligibility Criteria

Age30 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years old
  • Unexplained infertility

You may not qualify if:

  • Presence of other causes of infertility,
  • age out of the predetermined range,
  • the presence of immune disorders,
  • maintenance on immunosuppressive drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Banha University

Banhā, El- Qalyobia, 13511, Egypt

Location

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor of gynecology

Study Record Dates

First Submitted

December 26, 2022

First Posted

January 11, 2023

Study Start

November 7, 2020

Primary Completion

November 12, 2021

Study Completion

March 25, 2022

Last Updated

January 11, 2023

Record last verified: 2022-12

Locations